DW

David Wu

Independent Director at Seraphina Therapeutics

San Francisco Bay Area

Overview

Work Experience

  • Venture Partner

    2022 - Current

  • General Partner

    2012 - 2022

  • Independent Director

    2024

    Manufacturer of Fatty15, the world’s first, and only science-backed, patented, award-winning C15:0 supplement that supports your long-term health & wellness.

  • Independent Director

    2024

    Compensation Committee.

  • Member, Board of Directors

    2022

    Nominations & governance committee, finance committee, audit committee, marketing committee, and GRAMMY Blue Ribbon Adjudication Committee.

  • Member, Board of Directors

    2020

    Compensation committee.

  • Member, Board of Directors

    2018

  • Member, Board of Directors

    2016

    Audit committee.

  • Independent Director

    2013 - 2024

    Eargo went public (NASDAQ: EAR) in 2020. Audit committee chair, compensation committee, and special committee.

  • Member, Board of Directors

    2021 - 2024

  • Member, Board Of Directors

    2017 - 2022

    Inkbox was acquired by BiC in 2022.

Relevant Websites